DV
Dividend Vision

LAB — Standard Biotools Inc

Standard Biotools Inc (LAB)

Total return is -94.9% over the past 15.5 years, 765.9 points behind SPY at 671.0%. Its deepest 1-year drawdown was 56.5%.

LAB is an equity stock fund that provides exposure to Standard Biotools Inc, a company operating in the biotechnology sector. The fund does not currently maintain a dividend distribution program, as indicated by its N/A distribution rate and frequency. With limited publicly available data on expense ratio and assets under management, this holding appeals primarily to investors seeking direct equity exposure to the biotools industry rather than those focused on generating regular dividend income.

LAB key facts

Asset type
Stock
Asset class
Equity
Inception date
02/10/2011
Last close
$0.71
Market cap
$346,092,384
Average volume
1302900.0
Beta
1.422
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.13